Paridiprubart (anti-TLR4) is a humanised anti-TLR4 monoclonal antibody. Paridiprubart (anti-TLR4) has the potential for the research of rheumatoid arthritis.
Cooperates with LY96 and CD14 to mediate the innate immune response to bacterial lipopolysaccharide (LPS). Acts via MYD88, TIRAP and TRAF6, leading to NF-kappa-B activation, cytokine secretion and the inflammatory response. Also involved in LPS-independent inflammatory responses triggered by Ni(2+). These responses require non-conserved histidines and are, therefore, species-specific.
Post-translational: N-glycosylated. Glycosylation of Asn-526 and Asn-575 seems to be necessary for the expression of TLR4 on the cell surface and the LPS-response. Likewise, mutants lacking two or more of the other N-glycosylation sites were deficient in interaction with LPS.
宿主种属
人(Human)
特异性
TLR4
种属反应性
人(Human)
偶联
Unconjugated
作用类型
抑制剂
克隆类型
重组抗体
Format
Whole IgG
亚型
Human IgG1
轻链亚型
kappa
纯化方法
Protein A purified
浓度
见COA
CAS编号和信息
2641646-59-3
分子类型
抗体
储存与运输
储存缓冲液
Supplied as a 0.22μm filtered solution in 100mM Pro-Ac, 20mM Arg, pH 5.0
防腐剂
No
储存条件
-80℃储存,避免反复冻融
运输条件
特低温运输
稳定性与储存
在 -80℃ 下保存 24 个月。收货后建议分装。避免冷冻/解冻循环。
图片
Paridiprubart (anti-TLR4) (Ab191908) - Flow Cytometry Flow Cytometry analysis of human peripheral blood monocytes labelling TLR4 with Paridiprubart (anti-TLR4) (Ab191908) conjugated with biotin (right panel) compared with Human IgG (Biotin) (Ab180314) - Isotype Control (left panel) and detected with SA-PE (rp156150).
Paridiprubart (anti-TLR4) (Ab191908) - Flow Cytometry Flow Cytometry analysis of human peripheral blood lymphocytes labelling TLR4 (red) with Paridiprubart (anti-TLR4) (Ab191908) conjugated with biotin and detected with SA-PE (rp156150). Blue - Isotype control, Human IgG (Biotin) (Ab180314). Black - Unlabelled control, cells without incubation with primary antibody.
Paridiprubart (anti-TLR4) (Ab191908) - Flow Cytometry Flow Cytometry analysis of pLVX-puro-SYPX23-C017-hu-TLR4-P2A-EGFP cells labelling TLR4 (red) with Paridiprubart (anti-TLR4) (Ab191908) at 1×105 cell/well, with the EC50 is 0.10 μg/mL.
Paridiprubart (anti-TLR4) (Ab191908) - SEC The purity of Paridiprubart (anti-TLR4) (Ab191908) is more than 95% verified by HPLC.